Showing results (221-230 of 238) with videos related to
Sort By:
Pageof 24
Molecular Cancer Therapeutics|October 28, 2010
SCH 2047069, a novel oral kinesin spindle protein inhibitor, shows single-agent antitumor activity and enhances the efficacy of chemotherapeuticsAndrea D Basso, Ming Liu, Chaoyang Dai, et al.Prostate Cancer and Prostatic Diseases|February 10, 2016
Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional reviewA Leone, B Gershman, K Rotker, et al.Biochemistry|August 20, 2010
Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domainPayal R Sheth, Gerald W Shipps, Wolfgang Seghezzi, et al.Journal of Endocrinological Investigation|July 17, 2023
Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemiaS Censi, S Carducci, G Zoppini, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitorsZhaoyang Meng, Bheemashankar A Kulkarni, Angela D Kerekes, et al.Cancer Chemotherapy and Pharmacology|February 8, 2011
SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitorsAndrea D Basso, Ming Liu, Kimberly Gray, et al.Journal of Medicinal Chemistry|December 7, 2010
Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposureAngela D Kerekes, Sara J Esposite, Ronald J Doll, et al.JACC. Heart Failure|January 14, 2020
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to SpironolactoneJordana B Cohen, Sarah J Schrauben, Lei Zhao, et al.Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitorsDavid B Belanger, Michael J Williams, Patrick J Curran, et al.Journal of the American College of Cardiology|March 21, 2020
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection FractionJulio A Chirinos, Alena Orlenko, Lei Zhao, et al.Pageof 24